½ºÄ³Æúµå ±â¼ú ½ÃÀå : À¯Çüº°, Áúº´ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¹× Àü¸Á(2023-2030³â)
Scaffold Technology Market with COVID-19 Impact Analysis, By Type, By Disease Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size,Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1304639
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2023³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 333 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,474,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,401,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,778,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ÀÇ ÇÏÀ̶óÀÌÆ®

½ºÄ³Æúµå ±â¼ú ½ÃÀå ±Ô¸ð´Â 2022³â 14¾ï 890¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023³âºÎÅÍ 2030³â±îÁö 19.8%ÀÇ CAGR·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ºÄ³Æúµå ±â¼ú ½ÃÀå - ½ÃÀå ¿ªÇÐ:

3D ¼¼Æ÷¹è¾ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

3D ¹è¾ç¿¡¼­´Â ½ºÄ³Æúµå ±â¹Ý Ç÷§ÆûÀÌ »ç¿ëµÇ¾î ¼¼Æ÷°¡ 3D ¼ºÀåÀ» ½±°Ô ÇÒ ¼ö Àִ ǥ¸éÀ» Á¦°øÇÔÀ¸·Î½á ¼¼Æ÷ ¹è¾ç ÀýÂ÷¸¦ º¯°æÀï´Ï´Ù. ¶ÇÇÑ, ½ºÄ³Æúµå ±â¼ú¿¡¼­ ¼¼Æ÷´Â ÇÕ¼º ¹°ÁúÀ̳ª ¼¼Æ÷ ¿Ü ¸ÅÆ®¸¯½º ³»¿¡¼­ Áõ½ÄÇÕ´Ï´Ù. ½ºÄ³Æúµå ±â¼ú, Ȱ¼ºÈ­ ¹× ¼¼Æ÷ Á¢ÂøÀº ½ºÄ³ÆúµåÀÇ Æ¯¼º°ú ½ºÄ³Æúµå Àç·áÀÇ Æ¯¼º¿¡ µû¶ó ´Þ¶óÁý´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î Á¶Á÷ÀÇ Çü¼º ¼Óµµ¿Í ÇÊ¿äÇÑ ±â°èÀû ±â´ÉÀ» ´Þ¼ºÇϱâ À§Çؼ­´Â ºÐÇØ ¼Óµµ, ½ºÄ³ÆúµåÀÇ Æ¯¼º, Àç·á µî ´Ù¾çÇÑ Æ¯¼ºÀ» ƯÁ¤ ¿ëµµ¿¡ ¸Â°Ô º¯°æÇØ¾ß ÇÕ´Ï´Ù. ½ºÄ³ÆúµåÀÇ ³ëÃâµÈ Ç¥¸éÀû, ±â°ø ºÐÆ÷ ¹× ´Ù°ø¼ºÀº ¼¼Æ÷¿Ü ¸ÅÆ®¸¯½ºÀÇ ±¸Á¶, ¼¼Æ÷ÀÇ Ä§Åõ ¼Óµµ, ħÅõ¼º ¹× Àç»ý °úÁ¤ÀÇ ÃÖÁ¾ È¿°ú¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ½ºÄ³Æúµå¸¦ »ç¿ëÇÏÁö ¾Ê´Â ¼¼Æ÷ ¹è¾ç ±â¼úÀÇ ÃâÇö°ú µµÀÔ¿¡ µû¸¥ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¼¼°è ½ºÄ³Æúµå ±â¼ú ½ÃÀåÀÇ ¼ºÀå ±Ô¸ð´Â Á¶Á÷ °øÇÐ ¹× ½Åü Àç°Ç¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, »ýü Àç·á »ç¿ë·® Áõ°¡, ½ºÄ³Æúµå ±â¼ú ±â¼ú ¹ßÀüÀÇ ¼ºÀå¿¡ ÀÇÇØ Å©°Ô ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

½ºÄ³Æúµå ±â¼ú ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®:

½ºÄ³Æúµå ±â¼ú ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

½ºÄ³Æúµå ±â¼ú ½ÃÀå - Áö¸®Àû ÅëÂû·Â :

Áö¸®ÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«À¸·Î ³ª´¹´Ï´Ù. ÀÌ Áö¿ªµéÀº »ç¾÷ ¿î¿µ ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù.

½ºÄ³Æúµå ±â¼ú ½ÃÀå - °æÀï ±¸µµ:

Á¶Á÷ÀÇ ¼öº¹ ¹× Àç»ýÀ» À§ÇÑ ¿©·¯ Á¶Á÷À» Á¦Á¶Çϱâ À§ÇØ ¾÷°è´Â ´Ù¾çÇÑ ±â¼úÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, DMS´Â »ý¹°ÇÐÀû ¼ö¼ú¿ë µå·¡ÇÁÆ®¸¦ »ý»êÇϱâ À§ÇØ µ¶ÀÚÀûÀÎ OPTRIX ±â¼úÀ» Ȱ¿ëÇÏ¿© Æ÷½Å ÁÖµµÇü Á¶Á÷À» °¡°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¼ö¼ú¿ë µå·¡ÇÁÆ®´Â ¿¬ºÎÁ¶Á÷ÀÇ °á¼ÕÀ» º¹±¸ÇÏ°í º¸°­ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¶ÇÇÑ, OPTRIX Á¶Á÷Àº ´Ù¾çÇÑ Á¶Á÷ ¼Ò½º¸¦ Áö¿øÇϱ⠶§¹®¿¡ ´Ù¾çÇÑ ÀÓ»ó Àû¿ëÀ» À§ÇÑ ¿¬Á¶Á÷ »ý¼º Á¦Ç° °³¹ß¿¡ Àû¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 4¿ù ¿¡º¸´Ð°ú º§¶ó¼¼³ë´Â °øµ¿À¸·Î »À Àç»ýÀ» À§ÇÑ 3D ÇÁ¸°ÆÃ ½ºÄ³Æúµå¸¦ »ó¿ëÈ­Çß½À´Ï´Ù. ¶ÇÇÑ, »À ½ºÄ³Æúµå´Â ¿¡º¸´ÐÀÇ ·¹Á¶¸Ó Æú¸®¸Ó·Î Á¦ÀÛµÇ¾î º¹ÀâÇϰí Å« »À °á¼Õ ºÎÀ§¿¡ »ç¿ëµË´Ï´Ù.

ÃÖ±Ù µ¿Çâ

¿¹¸¦ µé¾î, 2023³â 1¿ù ReLive Biotechnologies, Ltd.´Â µ¶ÀÏ »óÀå »ý¸í°øÇÐ ±â¾÷ Co.Don AG(CNW.DF)ÀÇ Àμö(ÀÌÇÏ "Àμö")¸¦ ¹ßÇ¥ÇÏ¿© ÁÖ·Â Á¦Ç°ÀÎ "Spherox"¿Í "Chondrosphere"¿¡ ´ëÇÑ ¼¼°è ƯÇã±ÇÀ» ȹµæÇß½À´Ï´Ù. '½ºÆä·Ï½º'´Â °üÀý¿¬°ñ°á¼Õ Àç»ýÄ¡·áÁ¦·Î¼­ ¼¼°è¿¡¼­ À¯ÀÏÇÏ°Ô Çã°¡¹ÞÀº µÎ °¡Áö ¼¼Æ÷Ä¡·áÁ¦ Áß ÇϳªÀÔ´Ï´Ù.

Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ º¸°í¼­´Â 2022³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ½ÃÀå ±Ô¸ð, ¿¬Æò±Õ ¼ºÀå·ü(CAGR%), ÃßÁ¤ ¹× ¿¹Ãø(2023-2030³â)À» Á¦°øÇÏ´Â ½ºÄ³Æúµå ±â¼ú ½ÃÀå¿¡ ´ëÇÑ Á¶»ç º¸°í¼­ÀÔ´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â °í°´¿¡°Ô ½ºÄ³Æúµå ±â¼ú ½ÃÀå¿¡ ´ëÇÑ Ãֽе¿Çâ°ú ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â ´Ù¾çÇÑ ºÎ¹®/±¹°¡¿¡ °ÉÃÄ ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ½ºÄ³Æúµå ±â¼ú ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â Àü¹ÝÀûÀÎ º¸°í¼­¿¡¼­ »õ·Î¿î ÅõÀÚ ±âȸ, ±âÁ¸ ±â¾÷ÀÌ Á÷¸éÇÑ °úÁ¦, ±×¸®°í ½ºÄ³Æúµù ±â¼ú ½ÃÀå¿¡¼­ Áö¼Ó °¡´ÉÇÑ ¼ºÀå ¿äÀÎÀ» ÆÄ¾ÇÇÕ´Ï´Ù.

Äڷγª19°¡ ½ºÄ³Æúµå ±â¼ú ½ÃÀå ±Ô¸ð, ¿¹Ãø, CAGR, ½ÃÀå ¿ªÇп¡ ¹ÌÄ¡´Â ¿µÇâÀº ¿¬±¸ ¹üÀ§¿¡¼­ ÀÚ¼¼È÷ ³íÀǵǸç, COVID ÀÌÈÄ ½ºÄ³Æúµå ±â¼ú ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Âµµ ´Ù·ç¾îÁý´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ »ç¿ëÀÚ¿¡°Ô ½ºÄ³Æúµå ±â¼ú ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ °üÁ¡À» Á¦°øÇϱâ À§ÇØ ½ºÄ³Æúµå ±â¼ú ½ÃÀå °æÀï ±¸µµ¿Í ÁÖ¿ä Çõ½Å°¡ ºÐ¼®µµ ÇÔ²² Á¦°øµË´Ï´Ù.

ÀÌ º¸°í¼­´Â ½ÃÀå ±Ô¸ð, ¼ºÀå·ü, ¸Å·Âµµ¸¦ ±âÁØÀ¸·Î ¸ðµç »ê¾÷ ºÎ¹®À» º¥Ä¡¸¶Å·ÇÏ´Â ¼ºÀå Àü¸Á ¸ÅÇÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ »ó¼¼ÇÑ ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ÅëÇØ ½ºÄ³Æúµå ±â¼ú ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇÏ´Â ±â¾÷ÀÇ À繫 Á¤º¸ ¹× Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¼¼°è»Ó¸¸ ¾Æ´Ï¶ó Áö¿ªÀû Â÷¿ø¿¡¼­µµ ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀÇ ÁÖ¿ä ÀμöÇÕº´, Á¦ÈÞ ¹× ÇÕÀÛÅõÀÚ, ½ÅÁ¦Ç° Ãâ½Ã, ¿¬±¸°³¹ß, Áö¿ª ÁøÃâ¿¡ ´ëÇØ¼­µµ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ºÄ¿Æúµå ±â¼ú ¼¼°è ½ÃÀå º¸°í¼­´Â ÁÖ·Î °ø±Þ¾÷ü, ÅõÀÚÀÚ, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À¯Åë¾÷ü, ±ÝÀ¶ ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ºÄ³Æúµå ±â¼ú ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ºÄ³Æúµå ±â¼ú ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ½ºÄ³Æúµå ±â¼ú »ê¾÷ Á¶»ç

Á¦5Àå ½ºÄ³Æúµå ±â¼ú ½ÃÀå : COVID-19Áõ ¿µÇ⠺м®

Á¦6Àå ½ºÄ³Æúµå ±â¼ú ½ÃÀå ±¸µµ

Á¦7Àå ½ºÄ³Æúµå ±â¼ú ½ÃÀå - À¯Çüº°

Á¦8Àå ½ºÄ³Æúµå ±â¼ú ½ÃÀå - Áúȯ À¯Çüº°

Á¦9Àå ½ºÄ³Æúµå ±â¼ú ½ÃÀå - ¿ëµµº°

Á¦10Àå ½ºÄ³Æúµå ±â¼ú ½ÃÀå - ÃÖÁ¾ ¿ëµµº°

Á¦11Àå ½ºÄ³Æúµå ±â¼ú ½ÃÀå - Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - ½ºÄ³Æúµå ±â¼ú ¾÷°è

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ ´Ù°¢Àû °ßÇØ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Scaffold technology market size was valued at USD 1,408.9 Million in 2022, expanding at a CAGR of 19.8% from 2023 to 2030.

Scaffolds are used to assist organs and systems organs that may have been damaged after an injury or disease. Additionally, it is done by using tissue engineering as well as regenerative medicines. Tissue engineering is the process of enhancing or replacing biological processes by the combination of cells with the appropriate biochemical and physio-chemical elements. Scaffolds are either directly implanted to the injured site or cultured in vitro to synthesize tissue. Moreover, scaffolds are produced by using numerous biomaterials and different fabrication of techniques.

Scaffold Technology Market- Market Dynamics:

Increasing use of 3D cell culture is gaining demand

In 3D culture, scaffold-based platforms are used to alter the cell culture procedure by offering a surface on which the cells can easily impart 3D growth. Additionally, the cells are grown within synthetic materials and extracellular matrix in scaffold technology. Scaffold technology, activation, and cell adhesion depend on scaffold characteristics and scaffold material properties. Moreover, to accomplish the rate of new-tissue formation and required mechanical function, different characteristics, including degradation kinetic, scaffold properties, and materials, be altered to match the specific application. Exposed surface area, pore distribution, and porosity of the scaffold can impact the architecture of the extracellular matrix, the rate of penetration of cells, penetration, and the final effectiveness of the regenerative process. However, the emergence of scaffold-free technology for cell culturing and the high cost associated with implementation are expected to restrain the market growth. Furthermore, the worldwide scaffold technology market growth size is significantly driven by the increase in demand for tissue engineering and body reconstruction procedures, the rise in usage of biomaterials, and the technological advancement growth of scaffold technology.

Scaffold Technology Market- Key Insights:

Scaffold Technology Market- Segmentation Analysis:

Scaffold Technology Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Scaffold Technology Market- Competitive Landscape:

Proprietary technologies are developed by industry players for manufacturing multiple tissues for tissue repair and regeneration. Additionally, for manufacturing biological surgical drafts DMS process porcine-driven tissues by utilizing proprietary OPTRIX technology. These surgical drafts are used to repair and reinforce soft tissue defects. Moreover, for multiple tissues source, OPTRIX tissues can be applied to develop soft tissue generation products for numerous clinical applications. For instance, in April 2023, Evonik and BellaSeno collaborated to commercialize 3D-Printed Scaffolds for Bone Regeneration. In addition, the bone scaffolds are built with Evonik's Resomer polymers and are used for complex and large bone defects.

Recent Developments:

For instance, in January 2023, ReLive Biotechnologies, Ltd. announced the acquisition of Germany-listed biotech company Co.Don AG (CNW.DF) ("Acquisition"), acquiring the global patent rights of its flagship products "Spherox" and "Chondrosphere". Additionally, "Spherox" is one of the only two authorized cell therapies for the regenerative treatment of articular cartilage defects worldwide.

Key features of the study:

This proposed research study on scaffold technology market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The report provides the client the latest up-to-date and trending insights about the scaffold technology market.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for scaffold technology market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the scaffold technology market.

Impact of COVID-19 on scaffold technology market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on scaffold technology market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the scaffold technology market, we have also included competitive landscape and key innovator analysis for the scaffold technology market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the scaffold technology market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global scaffold technology market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SCAFFOLD TECHNOLOGY MARKET KEY PLAYERS

GLOBALSCAFFOLD TECHNOLOGY MARKET, BY TYPE

GLOBAL SCAFFOLD TECHNOLOGY MARKET, BY DISEASE TYPE

GLOBAL SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION

GLOBAL SCAFFOLD TECHNOLOGY MARKET, BY END-USE

GLOBAL SCAFFOLD TECHNOLOGY MARKET, BY REGION

Table of Contents

1. Scaffold Technology Market Overview

2. Executive Summary

3. Scaffold Technology Key Market Trends

4. Scaffold Technology Industry Study

5. Scaffold Technology Market: COVID-19 Impact Analysis

6. Scaffold Technology Market Landscape

7. Scaffold Technology Market - By Type

8. Scaffold Technology Market - By Disease Type

9. Scaffold Technology Market - By Application

10. Scaffold Technology Market - By End-Use

11. Scaffold Technology Market- By Geography

12. Key Vendor Analysis- Scaffold Technology Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â